Partner Content Partner Content Four weeks until Adaptive Designs in Clinical Trials Confere... Four weeks until SMi’s 11th Annual Conference
Partner Content Partner Content Pfizer’s vice president & Head of Early Clinical Develop... Adaptive Designs in Clinical Trials 2019
Partner Content Partner Content SMi’s Adaptive Design in Clinical Trials - 4 days to go SMi’s Adaptive Design in Clinical Trials
News New data could widen use of Novartis' SMA therapy Zolgensma Phase 3 results with an intrathecal version of Novartis spinal muscular atrophy (SMA) gene therapy could make older children eligible for treatment.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
